Blocking both ICAM-1 and VCAM-1 did not reduce IGF1R or AKT activation in T-ALL cells more than blocking either adhesion molecule individually (Supplementary Fig. 6a, b), despite more significantly reducing T-ALL survival (Fig. 2a). The gene discussed is IGF1R; the disease is acute lymphoblastic leukemia.